Open AccessAddition of SGLT2 inhibitors in type 2 diabetes is associated with persistent and significant weight loss: a real-world study from Eastern India
Author(s) -
Rishad Ahmed,
Soumobroto Roy Choudhury,
Debmalya Sanyal,
Anirban Majumder
Publication year - 2022
Publication title -
clinical diabetology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.152
H-Index - 4
eISSN - 2450-8187
pISSN - 2450-7458
DOI - 10.5603/dk.a2022.0008
Subject(s) - medicine , weight loss , empagliflozin , canagliflozin , body mass index , dapagliflozin , glycemic , type 2 diabetes mellitus , diabetes mellitus , type 2 diabetes , obesity , endocrinology